SCHEMBL10035397

SCHEMBL10035397

CCCOB(OCCC)c1cc2ccccc2c2c1sc1ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.36
ATM Q13315 1/20 0.36
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 5/20 0.34
HTT P42858 4/20 0.34
HPGD P15428 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
HCRTR1 O43613 1/20 0.34
MAPT P10636 6/20 0.33
RAB9A P51151 4/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ELANE P08246 1/20 0.33
PKM P14618 1/20 0.33
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
TP53 P04637 1/20 0.32
HSD17B10 Q99714 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035398 0.93 ALDH1A1 (0.36) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035417 0.91 L3MBTL1 (0.34) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035407 0.90 CNR2 (0.33) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035406 0.90 L3MBTL1 (0.37) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035414 0.85 KDM4E (0.37) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035415 0.82 ALDH1A1 (0.40) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035419 0.79 ALDH1A1 (0.36) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL10035405 0.79 ALDH1A1 (0.36) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL9950434 0.78 MAPT (0.42) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL14983528 0.76 TRPM4 (0.36) MEN1KMT2AALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-8674117-B2 Organoboron compound and method for manufacturing the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-03-18 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165550-A1 Organoboron Compound and Method for Manufacturing the Same CYP2B6, CBR3, CBR1 L3MBTL1 2201/4885ATM 1693/4885MEN1 1969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.